Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

150
Delayed Quote. Delayed London Stock Exchange - 10/22 11:35:18 am
1377 GBp   +2.61%
7h agoDJHealth Care Down as Biogen, Intuitive Surgical Weigh -- Health Care Roun..
8h ago Global shares falter as Wall St. tumbles, bond prices fall
8h ago Shares falter as Wall Street tumbles, bond prices fall
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Sales27 38726 43126 50523 52625 00225 728
Operating income (EBITDA)10 2319 4158 8838 0158 1568 568
Operating profit (EBIT)8 5548 3308 0156 6286 8767 158
Pre-Tax Profit (EBT)7 6986 6926 6474 8145 4316 021
Net income5 2614 5655 6283 6413 6244 068
EPS (PNC)10391,511174,688,885,5
Dividend per Share (PNC)70,074,078,080,882,884,8
Yield5,22%5,51%5,81%6,02%6,17%6,32%
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Debt9 00314 03712 64512 65510 88111 029
Finance------
Operating income (EBITDA)10 2319 4158 8838 0158 1568 568
Leverage
(Debt/EBITDA)
0,88x1,49x1,42x1,58x1,33x1,29x
Capital Expenditure9231 0511 1881 4331 4841 507
Book Value Per Share (BVPS)162 PNC120 PNC146 PNC138 PNC123 PNC129 PNC
Cash Flow per Share124 PNC87,7 PNC149 PNC109 PNC117 PNC139 PNC
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 65 084 M GBP -
Entreprise Value (EV) 77 738 M GBP 75 964 M GBP
Valuation 2014e 2015e
PER (Price / EPS) 18,0x 15,1x
Capitalization / Revenue 2,77x 2,60x
EV / Revenue 3,30x 3,04x
EV / EBITDA 9,70x 9,31x
Yield (DPS / Price) 6,02% 6,17%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 28,2% 27,5%
operating Leverage (Delta EBIT / Delta Sales) -1,54x 0,60x
Net Margin (Net Profit / Revenue) 15,5% 14,5%
ROA (Net Profit / Asset) 7,70% 7,70%
ROE (Net Profit / Equities) 61,0% 67,5%
Rate of Dividend 108% 93,3%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   6,09% 5,94%
Cash Flow / Sales (Taux d'autofinancement) 22,4% 22,6%
Capital Intensity (Assets / Sales) 2,01x 1,88x
Financial Leverage (Net Debt / EBITDA) 1,58x 1,33x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF